Global WholeHealth Partners Corp. announced that they had acquired the rights to be able to distribute and sell both Pfizer-BioTech and Johnson & Johnson’s COVID-19 vaccine, announced that they have now, also, acquired the rights to sell and distribute Moderna’s vaccine. As with the Johnson & Johnson 8K filed on June 10, 2021, for the J&J rights, the Company filed on June 16, 2021, for Pfizer and filed for Moderna on June 25, 2021, stating that “Effective June 22, 2021, Global WholeHealth Partners Corporation was granted the rights from Nunzia Pharmaceutical Inc. (“Nunzia”) to distribute and sell the Moderna COVID-19 Vaccine. The Company will serve as a broker for Nunzia and follow the same sales order processing as used by Nunzia in connection with the distribution and sale of the Vaccine. The Company already offers one of the largest lines of COVID 19 tests, including the strains identified in the United Kingdom (B.1.1.7), South Africa (B.1.351), and Brazil (P.1) strain contains multiple mutations, most reflected in the S gene, which encodes the spike protein.